Description
Organized by the National Cancer Policy Forum, this October 2007 workshop explored new approaches to...
Read More
Organized by the National Cancer Policy Forum, this October 2007 workshop explored new approaches to clinical trial design and execution that would better inform decisions and plans of those responsible for developing cancer therapies, more rapidly move new diagnostic tests and treatments toward regulatory approval, and be less costly than current trials. The workshop summary reports participant presentations on molecular imaging, screening for predictive markers, regulatory issues, and collaboration among academia, the pharmaceutical industries, and government. No index is provided. Annotation ©2008 Book News, Inc., Portland, OR (booknews.com)
Read Less